Prediction of "aggregation-prone" and "aggregation- susceptible" regions in proteins associated with neurodegenerative diseases

Journal of Molecular Biology

Volumn 350, Issue 2, 2005, Pages 379-392

  Pawar, Amol P ^a   DuBay, Kateri F ^a,c   Zurdo, Jesús ^a   Chiti, Fabrizio ^b   Vendruscolo, Michele ^a   Dobson, Christopher M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid; Protein aggregation; Protein misfolding; Sensitive regions

Indexed keywords

A BETA 42 PEPTIDE; ALPHA SYNUCLEIN; AMINO ACID; AMYLOID; POLYPEPTIDE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; DEGENERATIVE DISEASE; MUTATION; PREDICTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION;

EID: 20444403757     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.04.016     Document Type: Article

References (100)

1. R.J. Ellis Macromolecular crowding: obvious but underappreciated Trends Biochem.Sci. 26 2001 597 604
2. A.P. Minton Implications of macromolecular crowding for protein assembly Curr. Opin. Struct. Biol. 10 2000 34 39
3. C.M. Dobson Protein misfolding, evolution and disease Trends Biochem. Sci. 24 1999 329 332
4. M. Vendruscolo, J. Zurdo, C.E. MacPhee, and C.M. Dobson Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems Phil. Trans. Roy. Soc. ser. A 361 2003 1205 1222
5. C.M. Dobson The structural basis of protein folding and its links with human disease Phil. Trans. Roy. Soc. ser. B 356 2001 133 145
6. A.L. Horwich, and J.S. Weissman Deadly conformations - protein misfolding in prion disease Cell 89 1997 499 510
7. J.W. Kelly The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways Curr. Opin. Struct. Biol. 8 1998 101 106
8. J.C. Rochet, and P.T. Lansbury Amyloid fibrillogenesis: themes and variations Curr. Opin. Struct. Biol. 10 2000 60 68
9. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
10. M. Stefani, and C.M. Dobson Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution J. Mol. Med. 81 2003 678 699
11. F. Chiti, P. Webster, N. Taddei, A. Clark, M. Stefani, G. Ramponi, and C.M. Dobson Designing conditions for in vitro formation of amyloid protofilaments and fibrils Proc. Natl Acad. Sci. USA 96 1999 3590 3594
12. J.I. Guijarro, M. Sunde, J.A. Jones, I.D. Campbell, and C.M. Dobson Amyloid fibril formation by an SH3 domain Proc. Natl Acad. Sci. USA 95 1998 4224 4228
13. V.N. Uversky, and A.L. Fink Conformational constraints for amyloid fibrillation: the importance of being unfolded BBA-Proteins Proteomics 1698 2004 131 153
14. P.J. Muchowski Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron 35 2002 9 12
15. M. Citron, D. Westaway, W.M. Xia, G. Carlson, T. Diehl, and G. Levesque Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice Nature Med. 3 1997 67 72
16. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555
17. Tofaris, G. K., Razzaq, A., Ghetti, B., Lilley, K., Spillantini, M. G. (2003). Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 298, 44405-44411.
18. M. Abrahamson, and A. Grubb Increased body-temperature accelerates aggregation of the Leu-68-Gln mutant cystatin-C, the amyloid-forming protein in hereditary cystatin-C amyloid angiopathy Proc. Natl Acad. Sci. USA 91 1994 1416 1420
19. A. Lomakin, D.S. Chung, G.B. Benedek, D.A. Kirschner, and D.B. Teplow On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants Proc. Natl Acad. Sci. USA 93 1996 1125 1129
20. J.D. Harper, and P.T. Lansbury Models of amyloid seeding in Alzheimier's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
21. Y. Kusumoto, A. Lomakin, D.B. Teplow, and G.B. Benedek Temperature dependence of amyloid beta-protein fibrillization Proc. Natl Acad. Sci. USA 95 1998 12277 12282
22. Y. Su, and P.T. Chang Acidic pH promotes the formation of toxic fibrils from beta-amyloid peptide Brain Res. 893 2001 287 291
23. J. Zurdo, J.I. Guijarro, J.L. Jimenez, H.R. Saibil, and C.M. Dobson Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain J. Mol. Biol. 311 2001 325 340
24. F. Chiti, N. Taddei, M. Bucciantini, P. White, G. Ramponi, and C.M. Dobson Mutational analysis of the propensity for amyloid formation by a globular protein EMBO J. 19 2000 1441 1449
25. A.D. Ferrao-Gonzales, S.O. Souto, J.L. Silva, and D. Foguel The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state Proc. Natl Acad. Sci. USA 97 2000 6445 6450
26. T. Konno Amyloid-induced aggregation and precipitation of soluble proteins: a electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril Biochemistry 40 2001 2148 2154
27. L. Tjernberg, W. Hosia, N. Bark, J. Thyberg, and J. Johansson Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides J. Biol. Chem. 277 2002 43243 43246
28. F. Chiti, M. Calamai, N. Taddei, M. Stefani, G. Ramponi, and C.M. Dobson Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases Proc. Natl Acad. Sci. USA 99 2002 16419 16426
29. M.L. de la Paz, K. Goldie, J. Zurdo, E. Lacroix, C.M. Dobson, A. Hoenger, and L. Serrano De novo designed peptide-based amyloid fibrils Proc. Natl Acad. Sci. USA 99 2002 16052 16057
30. D.E. Otzen, O. Kristensen, and M. Oliveberg Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly Proc. Natl Acad. Sci. USA 97 2000 9907 9912
31. R. Schwartz, S. Istrail, and J. King Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues Protein Sci. 10 2001 1023 1031
32. F. Chiti, N. Taddei, F. Baroni, C. Capanni, M. Stefani, G. Ramponi, and C.M. Dobson Kinetic partitioning of protein folding and aggregation Nature Struct. Biol. 9 2002 137 143
33. M.W. West, W.X. Wang, J. Patterson, J.D. Mancias, J.R. Beasley, and M.H. Hecht De novo amyloid proteins from designed combinatorial libraries Proc. Natl Acad. Sci. USA 96 1999 11211 11216
34. V. Villegas, J. Zurdo, V.V. Filimonov, F.X. Aviles, C.M. Dobson, and L. Serrano Protein engineering as a strategy to avoid formation of amyloid fibrils Protein Sci. 9 2000 1700 1708
35. Y. Kallberg, M. Gustafsson, B. Persson, J. Thyberg, and J. Johansson Prediction of amyloid fibril-forming proteins J. Biol. Chem. 276 2001 12945 12950
36. M.R. Hurle, L.R. Helms, L. Li, W.N. Chan, and R. Wetzel A role for destabilizing amino-acid replacements in light-chain amyloidosis Proc. Natl Acad. Sci. USA 91 1994 5446 5450
37. A. Quintas, M.J.M. Saraiva, and R.M.M. Brito The tetrameric protein transthyretin dissociates to a non-native monomer in solution - a novel model for amyloidogenesis J. Biol. Chem. 274 1999 32943 32949
38. M. Ramirez-Alvarado, J.S. Merkel, and L. Regan A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro Proc. Natl Acad. Sci. USA 97 2000 8979 8984
39. J.A. Siepen, and D.R. Westhead The fibril_one on-line database: mutations, experimental conditions, and trends associated with amyloid fibril formation Protein Sci. 11 2002 1862 1866
40. D.P. Smith, S. Jones, L.C. Serpell, M. Sunde, and S.E. Radford A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation J. Mol. Biol. 330 2003 943 954
41. D.R. Booth, M. Sunde, V. Bellotti, C.V. Robinson, W.L. Hutchinson, and P.E. Fraser Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
42. P.B. Stathopulos, J.A.O. Rumfeldt, G.A. Scholz, R.A. Irani, H.E. Frey, and R.A. Hallewell Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro Proc. Natl Acad. Sci. USA 100 2003 7021 7026
43. A.D. Williams, E. Portelius, I. Kheterpal, J.T. Guo, K.D. Cook, Y. Xu, and R. Wetzel Mapping A beta amyloid fibril secondary structure using scanning proline mutagenesis J. Mol. Biol. 335 2004 833 842
44. F. Chiti, M. Stefani, N. Taddei, G. Ramponi, and C.M. Dobson Rationalization of the effects of mutations on peptide and protein aggregation rates Nature 424 2003 805 808
45. K.F. Dubay, A.P. Pawar, F. Chiti, J. Zurdo, C.M. Dobson, and M. Vendruscolo Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains J. Mol. Biol. 341 2004 1317 1326
46. A.M. Fernandez-Escamilla, F. Rousseau, J. Schymkowitz, and L. Serrano Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins Nature Biotechnol. 22 2004 1302 1306
47. R. Linding, J. Schymkowitz, F. Rousseau, F. Diella, and L. Serrano A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins J. Mol. Biol. 342 2004 345 353
48. G.G. Tartaglia, A. Cavalli, R. Pellarin, and A. Caflisch The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates Protein Sci. 13 2004 1939 1941
49. R. Cowan, and R.G. Witthaker Hydrophobicity indices for amino acid residues as determined by HPLC Pept. Res. 3 1990 75 80
50. M.A. Roseman Hydrophilicity of polar amino-acid side-chains is markedly reduced by flanking peptide-bonds J. Mol. Biol. 200 1988 513 522
51. P. Koehl, and M. Levitt Structure-based conformational preferences of amino acids Proc. Natl Acad. Sci. USA 96 1999 12524 12529
52. B.M. Broome, and M.H. Hecht Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis J. Mol. Biol. 296 2000 961 968
53. O.S. Makin, E. Atkins, P. Sikorski, J. Johansson, and L.C. Serpell Molecular basis for amyloid fibril formation and stability Proc. Natl Acad. Sci. USA 102 2005 315 320
54. S.M. Tracz, A. Abedini, M. Driscoll, and D.P. Raleigh Role of aromatic interactions in amyloid formation by peptides derived from human amylin Biochemistry 43 2004 15901 15908
55. R. Azriel, and E. Gazit Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide - an experimental support for the key role of the phenylalanine residue in amyloid formation J. Biol. Chem. 276 2001 34156 34161
56. L.O. Tjernberg, D.J.E. Callaway, A. Tjernberg, S. Hahne, C. Lilliehook, and L. Terenius A molecular model of Alzheimer amyloid beta-peptide fibril formation J. Biol. Chem. 274 1999 12619 12625
57. J.J. Balbach, Y. Ishii, O.N. Antzutkin, R.D. Leapman, N.W. Rizzo, and F. Dyda Amyloid fibril formation by A beta(16-22), a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR Biochemistry 39 2000 13748 13759
58. A.T. Petkova, Y. Ishii, J.J. Balbach, O.N. Antzutkin, R.D. Leapman, F. Delaglio, and R. Tycko A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl Acad. Sci. USA 99 2002 16742 16747
59. M. Torok, S. Milton, R. Kayed, P. Wu, T. McIntire, C.G. Glabe, and R. Langen Structural and dynamic features of Alzheimer's A beta peptide in amyloid fibrils studied by site-directed spin labeling J. Biol. Chem. 277 2002 40810 40815
60. P.T. Lansbury, P.R. Costa, J.M. Griffiths, E.J. Simon, M. Auger, and K.J. Halverson Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide Nature Struct. Biol. 2 1995 990 998
61. C. Wurth, N.K. Guimard, and M.H. Hecht Mutations that reduce aggregation of the Alzheimer's A beta 42 peptide: an unbiased search for the sequence determinants of A beta amyloidogenesis J. Mol. Biol. 319 2002 1279 1290
62. G. Bitan, S.S. Vollers, and D.B. Teplow Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization J. Biol. Chem. 278 2003 34882 34889
63. G. Bitan, A. Lomakin, and D.B. Teplow Amyloid beta-protein oligomerization - prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins J. Biol. Chem. 276 2001 35176 35184
64. C. Nilsberth, A. Westlind-Danielsson, C.B. Eckman, M.M. Condron, K. Axelman, and C. Forsell The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced A beta protofibril formation Nature Neurosci. 4 2001 887 893
65. L. Miravalle, T. Tokuda, R. Chiarle, G. Giaccone, O. Bugiani, and F. Tagliavini Substitutions at codon 22 of Alzheimer's A beta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells J. Biol. Chem. 275 2000 27110 27116
66. W.E. Van Nostrand, J.P. Melchor, H.S. Cho, S.M. Greenberg, and G.W. Rebeck Pathogenic effects of D23N Iowa mutant amyloid beta-protein J. Biol. Chem. 276 2001 32860 32866
67. W.P. Esler, E.R. Stimson, J.R. Ghilardi, Y.A. Lu, A.M. Felix, and H.V. Vinters Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence Biochemistry 35 1996 13914 13921
68. S.J. Wood, R. Wetzel, J.D. Martin, and M.R. Hurle Prolines and amyloidogenicity in fragments of the Alzheimers peptide beta/A4 Biochemistry 34 1995 724 730
69. E. Maries, B. Dass, T.J. Collier, J.H. Kordower, and K. Steece-Collier The role of alpha-synuclein in Parkinson's disease: insights from animal models Nature Rev. Neurosci. 4 2003 727 738
70. H.Y. Han, P.H. Weinreb, and P.T. Lansbury The core Alzheimers peptide Nac forms amyloid fibrils which seed and are seeded by beta-amyloid - is Nac a common trigger or target in neurodegenerative disease Chem. Biol. 2 1995 163 169
71. H.N. Du, L. Tang, X.Y. Luo, H.T. Li, J. Hu, J.W. Zhou, and H.Y. Hu A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein Biochemistry 42 2003 8870 8878
72. O.M.A. El-Agnaf, and G.B. Irvine Aggregation and neurotoxicity of alpha-synuclein and related peptides Biochem. Soc. Trans. 30 2002 559 565
73. B.I. Giasson, I.V.J. Murray, J.Q. Trojanowski, and V.M.Y. Lee A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly J. Biol. Chem. 276 2001 2380 2386
74. A.K. Dunker, J.D. Lawson, C.J. Brown, R.M. Williams, P. Romero, and J.S. Oh Intrinsically disordered protein J. Mol. Graph. 19 2001 26 59
75. A. Der-Sarkissian, C.C. Jao, J. Chen, and R. Langen Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling J. Biol. Chem. 278 2003 37530 37535
76. W.X. Wang, and M.H. Hecht Rationally designed mutations convert de novo amyloid-like fibrils into monomeric beta-sheet proteins Proc. Natl Acad. Sci. USA 99 2002 2760 2765
77. J.S. Richardson, and D.C. Richardson Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation Proc. Natl Acad. Sci. USA 99 2002 2754 2759
78. D.E. Otzen, and M. Oliveberg Salt-induced detour through compact regions of the protein folding landscape Proc. Natl Acad. Sci. USA 96 1999 11746 11751
79. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, and S. Kosel Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nature Genet. 18 1998 106 108
80. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, and A. Dutra Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
81. K.A. Conway, J.D. Harper, and P.T. Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nature Med. 4 1998 1318 1320
82. A.R. Saha, J. Hill, M.A. Utton, A.A. Asuni, S. Ackerley, and A.J. Grierson Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons J. Cell Sci. 117 2004 1017 1024
83. J.J. Zarranz, J. Alegre, J.C. Gomez-Esteban, E. Lezcano, R. Ros, and I. Ampuero The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173
84. W. Choi, S. Zibaee, R. Jakes, L.C. Serpell, B. Davletov, R.A. Crowther, and M. Goedert Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein FEBS Letters 576 2004 363 368
85. K. Ueda, T. Saitoh, and H. Mori Tissue-dependent alternative splicing of messenger-Rna For Nacp, the precursor of non-A-beta component of Alzheimer's-disease amyloid Biochem. Biophys. Res. Commun. 205 1994 1366 1372
86. K. Beyer, J.I. Lao, C. Carrato, J.L. Mate, D. Lopez, I. Ferrer, and A. Ariza Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies Neuropathol. Appl. Neurobiol. 30 2004 601 607
87. I.V.J. Murray, B.I. Giasson, S.M. Quinn, V. Koppaka, P.H. Axelsen, and H. Ischiropoulos Role of alpha-synuclein carboxy-terminus on fibril formation in vitro Biochemistry 42 2003 8530 8540
88. L.C. Serpell, J. Berriman, R. Jakes, M. Goedert, and R.A. Crowther Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation Proc. Natl Acad. Sci. USA 97 2000 4897 4902
89. M.M. Dedmon, K. Lindorff-Larsen, J. Christodoulou, M. Vendruscolo, and C.M. Dobson Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations J. Am. Chem. Soc. 127 2005 476 477
90. T.C. Gamblin, R.W. Berry, and L.I. Binder Modeling Tau polymerization in vitro: a review and synthesis Biochemistry 42 2003 15009 15017
91. E.M. Ingram, and M.G. Spillantini Tau gene mutations: dissecting the pathogenesis of FTDP-17 Trends Mol. Med. 8 2002 555 562
92. M. Goedert, M.G. Spillantini, R. Jakes, D. Rutherford, and R.A. Crowther Multiple isoforms of human microtubule-associated protein-Tau - sequences and localization in neurofibrillary tangles of Alzheimers disease Neuron 3 1989 519 526
93. C.W. Wittmann, M.F. Wszolek, J.M. Shulman, P.M. Salvaterra, J. Lewis, M. Hutton, and M.B. Feany Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles Science 293 2001 711 714
94. T. Fath, J. Eidenmuller, and R. Brandt Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease J. Neurosci. 22 2002 9733 9741
95. M. Goedert, B. Ghetti, and M.G. Spillantini Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process Ann. NY Acad. Sci. 920 2000 74 83
96. M. von Bergen, P. Friedhoff, J. Biernat, J. Heberle, E.M. Mandelkow, and E. Mandelkow Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure Proc. Natl Acad. Sci. USA 97 2000 5129 5134
97. D. Schenk Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Nature Rev. Neurosci. 3 2002 824 828
98. C. Soto Unfolding the role of protein misfolding in neurodegenerative diseases Nature Rev. Neurosci. 4 2003 49 60
99. C.M. Dobson In the footsteps of alchemists Science 304 2004 1259
100. M. Dumoulin, A.M. Last, A. Desmyter, K. Decanniere, D. Canet, and G.R. Larsson A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme Nature 424 2003 783 788